BioNTech SE
Biotechnology Research • 
Mainz, Rhineland-Palatinate, Germany • 2001-5000 Employees
Company overview
| Headquarters | An der Goldgrube 12, Mainz, Rhineland-Palatinate 55131, DE |
| Phone number | +49613190840 |
| Websites | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Biotechnology, Rare Diseases, Oncology, Immunotherapy, Infectious Diseases, Cell Therapy, Small Molecule Immunomodulators, TCR, Antibody Therapeutics, Mrna Therapeutics, Bispecific Antibodies, Car T, Individualized Cancer Medicine, Patient-Specific Immunotherapy, Tailored Therapeutics |
| Founded | 2008 |
| Employees | 2001-5000 |
| Socials |
Key Contacts at BioNTech SE
Scott Smith
Director Talent Acquisition
Mohit Mittal
Associate Director, Service Delivery & Operations Leader, Global R&D Digital, Data & Informatics
Soeren Frickenschmidt
Senior Director Talent Acquisition
Anya Otteny
Associate Director Talent Acquisition Global Operations
Michael Megel
Associate Director It Data Analytics Platform Architecture
Giuseppe Lonetto
Director, Global Product Strategy
Marit Van Buuren
Senior Director, T Cell Immunology And Process Development
Daniel Gburek
Senior Director Data & Ai Platform
Rita Magenheim
Senior Director Clinical Development
Solomon Allotey-Pappoe
Director Data Strategy And Operational Excellence
BioNTech SE Email Formats
BioNTech SE uses 5 email formats. The most common is {first initial}.{last name} (e.g., j.doe@biontech.de), used 51.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@biontech.de | 60.7% |
{first name}.{last name} | john.doe@biontech.us | 36.8% |
About BioNTech SE
Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases. BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress. BioNTech was founded in 2008 by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. At BioNTech, we have been conducting fundamental research of mRNA technologies in the field of individualized cancer medicine for more than a decade. Some of our colleagues, including our co-founders, have been researching and developing mRNA-based vaccines for more than 25 years. Ready to join us on this journey? Explore the opportunities and become part of a team that aspires to turn bold ideas into real-world solutions: https://www.biontech.com/int/en/home/careers.html 🔗 Privacy Statement: https://www.biontech.com/int/en/home/data-privacy-statement.html 🔗 Imprint: https://www.biontech.com/int/en/home/imprint.html
BioNTech SE revenue & valuation
| Annual revenue | $2,860,900,000 |
| Revenue per employee | $573,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,154,900,000 |
| Total funding | $145,000,000 |
Employees by Management Level
Total employees: 2001-5000
Seniority
Employees
Employees by Department
BioNTech SE has 2,233 employees across 21 departments.
Departments
Number of employees
BioNTech SE Tech Stack
Discover the technologies and tools that power BioNTech SE's digital infrastructure, from frameworks to analytics platforms.
Font scripts
RUM
JavaScript frameworks
Programming languages
CDN
Security
Miscellaneous
Customer data platform
CMS
Tag managers
Miscellaneous
JavaScript libraries
United Arab Emirates
Pakistan
Italy
Frequently asked questions
4.8
40,000 users
